Strata Skin Sciences, Inc. (SSKN)
SSKN moved a median of 0.00% 30 minutes after news, and -0.33% by the close. How SSKN actually reacts to news — the realized, point-in-time move the market made, measured across 176 labeled events over the last three years with zero look-ahead.
SSKN’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 38% | 124 |
| 30-min | 0.00% | 39% | 148 |
| 60-min | -0.24% | 40% | 164 |
| to close | -0.33% | 39% | 175 |
| Middle 50% of SSKN reactions | -4.11% to +2.38% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 176 |
Half of all Strata Skin Sciences, Inc. news events land between -4.11% and +2.38% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when SSKN moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to SSKN's baseline. Nothing else.
Recent SSKN events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| STRATA Skin Sciences Appoints Medical Device Commercial Leader Erica Jordan as Chief Executive Officer | Press release | GlobeNewswire | +0.00% | -50.00% | |
| New Peer-Reviewed Publication Confirms Unprecedented Response Rates for STRATA’s Excimer Laser Combined with JAK Inhibitors in Pediatric Vitiligo | Press release | GlobeNewswire | +0.00% | +0.00% | |
| Form 10-K STRATA Skin Sciences, For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +0.00% | +3.73% | |
| Form EFFECT STRATA Skin Sciences, | SEC filing · Form EFFECT | SEC EDGAR | +0.00% | +13.04% | |
| Form 15-12G STRATA Skin Sciences, | SEC filing · Form 15-12G | SEC EDGAR | +0.00% | +15.56% | |
| Form POS AM STRATA Skin Sciences, | SEC filing · Form POS | SEC EDGAR | +15.11% | +0.00% | |
| Form S-8 POS STRATA Skin Sciences, | SEC filing · Form S-8 | SEC EDGAR | +15.11% | +0.00% | |
| Form 25 STRATA Skin Sciences, | SEC filing · Form 25 | SEC EDGAR | +0.00% | +8.76% | |
| STRATA Skin Sciences Confirms Nasdaq Delisting | Press release | GlobeNewswire | +0.00% | +8.76% | |
| Johns Hopkins Dermatology Expands Advanced Care for Inflammatory and Autoimmune Skin Conditions with Addition of XTRAC® Excimer Laser | Press release | GlobeNewswire | -10.53% | -33.36% | |
| STRATA Skin Sciences Highlights Meta-Analysis Confirming Clinical Efficacy of 308 nm Excimer Laser for Plaque Psoriasis | Press release | GlobeNewswire | -7.09% | +8.88% | |
| Form 8-K STRATA Skin Sciences, For: Feb 09 | SEC filing · Form 8-K | SEC EDGAR | -5.97% | -18.24% | |
| Form 8-K STRATA Skin Sciences, For: Dec 16 | SEC filing · Form 8-K | SEC EDGAR | -0.50% | -6.11% | |
| Form 8-K STRATA Skin Sciences, For: Dec 10 | SEC filing · Form 8-K | SEC EDGAR | +3.21% | +5.00% | |
| STRATA Skin Sciences Showcases XTRAC® and TheraclearX® at TeraCILAD 2025 — Reports Early Adoption Momentum in Mexico | Press release | GlobeNewswire | +0.69% | +2.80% | |
| Form 10-Q STRATA Skin Sciences, For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +3.36% | +8.96% | |
| STRATA Skin Sciences Announces CMS Recognition of Expanded CPT Codes for Inflammatory and Autoimmune Dermatologic Conditions with Company Anticipating Wider Excimer Adoption Ahead Of 2027 CPT Expansion | Press release | GlobeNewswire | -1.72% | -6.90% | |
| STRATA Skin Sciences to Report Third Quarter 2025 Financial Results on November 13, 2025 and Provide Corporate Update | Press release | GlobeNewswire | +0.00% | -2.30% | |
| Form DEF 14A STRATA Skin Sciences, For: Dec 10 | SEC filing · Form DEF | SEC EDGAR | -3.79% | -2.73% | |
| STRATA Skin Sciences Announces COFEPRIS Clearance of TheraClear® in Mexico and First Commercial Placements | Press release | GlobeNewswire | -0.48% | +14.88% | |
| Form PRE 14A STRATA Skin Sciences, For: Dec 10 | SEC filing · Form PRE | SEC EDGAR | -3.09% | -12.89% | |
| STRATA Skin Sciences Reinforces Market Leadership Following Key Litigation Milestones Against LaserOptek | Press release | GlobeNewswire | -0.06% | -1.03% | |
| Form 8-K STRATA Skin Sciences, For: Sep 26 | SEC filing · Form 8-K | SEC EDGAR | +0.62% | -2.07% | |
| Excimer Laser Demonstrates Promising Results in Treating Rare Variant of Cutaneous Lymphoma, Mycosis Fungoides | Press release | GlobeNewswire | -9.80% | -14.51% | |
| Form 8-K STRATA Skin Sciences, For: Oct 13 | SEC filing · Form 8-K | SEC EDGAR | -3.84% | -3.85% | |
| Marking Eczema Awareness Month – Clinical Research Validates Strata Skin Sciences’ XTRAC® Excimer Laser as a Breakthrough Therapy for Localized Atopic Dermatitis | Press release | GlobeNewswire | +0.94% | -0.47% | |
| STRATA Skin Sciences Receives Continued Validation for its Personalized Approach with New Published Study Highlighting XTRAC® Excimer Laser Treatment Combined with a Topical Drug in Psoriasis | Press release | GlobeNewswire | -4.45% | -6.36% | |
| New Peer Reviewed Publication of Combination Therapy in Vitiligo with STRATA Skin Sciences’ Excimer Laser and JAK Inhibitors Demonstrated Superior Safety and Unprecedented Response Rates, Providing Continued Validation of Personalized Medicine Approach | Press release | GlobeNewswire | +1.29% | +9.68% | |
| Form 8-K STRATA Skin Sciences, For: Sep 04 | SEC filing · Form 8-K | SEC EDGAR | +0.29% | +4.71% | |
| STRATA Skin Sciences Announces Closing of $2.42 Million Registered Direct Offering | Press release | GlobeNewswire | +0.29% | +4.71% | |
| STRATA Skin Sciences’ Elevate 360 Consulting Offering Drives Growth in Partner Clinic Operations and Fuels New Partnership Agreements | Press release | GlobeNewswire | -11.49% | -12.82% | |
| Form 8-K STRATA Skin Sciences, For: Sep 02 | SEC filing · Form 8-K | SEC EDGAR | +1.52% | -18.26% | |
| STRATA Skin Sciences Announces Pricing of $2.42 Million Registered Direct Offering of Common Stock Priced At-Market Under Nasdaq Rules | Press release | GlobeNewswire | +1.52% | -18.26% | |
| STRATA Skin Sciences IP Portfolio Holds Exclusivity in Combination Therapies of Its XTRAC Excimer Laser with JAK Inhibitors, Systemic and Biologic Drugs, Bolstering Expansion into New Indications Like Vitiligo and Other Auto-Immune Skin Conditions | Press release | GlobeNewswire | -3.23% | -20.73% | |
| STRATA Skin Sciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference | Press release | GlobeNewswire | +1.52% | -18.26% | |
| Form 8-K STRATA Skin Sciences, For: Aug 19 | SEC filing · Form 8-K | SEC EDGAR | — | -1.17% | |
| Form 8-K STRATA Skin Sciences, For: Aug 18 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -1.10% | |
| Form 10-Q STRATA Skin Sciences, For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -1.14% | -2.69% | |
| Form 8-K STRATA Skin Sciences, For: Aug 13 | SEC filing · Form 8-K | SEC EDGAR | -1.14% | -2.69% | |
| STRATA Skin Sciences Reports Second Quarter 2025 Financial Results and Provides a Corporate Update | Press release | GlobeNewswire | -1.14% | -2.69% | |
| Form 8-K STRATA Skin Sciences, For: Aug 07 | SEC filing · Form 8-K | SEC EDGAR | +2.63% | +0.52% | |
| STRATA Skin Sciences Moves to Accelerate Medicare and Private Payer Coverage from Expanded CPT Code Expansion, Tripling Addressable Market to 30M+ Patients | Press release | GlobeNewswire | +2.63% | +0.52% | |
| STRATA Skin Sciences to Report Second Quarter 2025 Financial Results on August 13, 2025 and Provide Corporate Update | Press release | GlobeNewswire | — | +0.52% | |
| Form 8-K STRATA Skin Sciences, For: May 19 | SEC filing · Form 8-K | SEC EDGAR | — | -3.98% | |
| STRATA Skin Sciences Announces Historic Expansion of CPT Codes for Reimbursement of 308nm Excimer Laser Treatments, Unlocking Access for Millions with Inflammatory and Auto-Immune Skin Diseases | Press release | GlobeNewswire | +14.00% | -0.80% | |
| Form 10-Q STRATA Skin Sciences, For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | — | -6.94% | |
| Form 8-K STRATA Skin Sciences, For: Mar 31 | SEC filing · Form 8-K | SEC EDGAR | — | -6.94% | |
| STRATA Skin Sciences Reports First Quarter 2025 Financial Results and Provides a Corporate Update | Press release | GlobeNewswire | — | -6.94% | |
| STRATA Skin Sciences to Participate in the D. Boral Capital Inaugural Global Conference | Press release | GlobeNewswire | — | -1.57% | |
| STRATA Skin Sciences to Report First Quarter 2025 Financial Results on May 14, 2025 and Provide Corporate Update | Press release | GlobeNewswire | — | -6.43% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the SSKN section they belong to.
Where else SSKN is measured.
SSKN earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Palatin Technologies, Inc. (PTN) | 177 | -0.54% | 45% |
| Rafael Holdings, Inc. Class B (RFL) | 176 | 0.00% | 43% |
| Capstone Holding Corp. (CAPS) | 175 | -2.00% | 35% |
| Ekso Bionics Holdings, Inc. (EKSO) | 175 | -0.12% | 39% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Strata Skin Sciences, Inc.'s median reaction calculated?
Every labeled SSKN news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 176 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 39% of SSKN's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does SSKN's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.